H47.22

Clinical Causes: Genetic mutations affecting mitochondrial DNA Inheritance primarily follows a maternal pattern, as mitochondria are inherited from the mother Some cases may involve mutations in nuclear DNA affecting mitochondrial function No clear environmental triggers are known, as the condition is genetic

Key Symptoms: Gradual loss of central vision, often beginning in early adulthood Reduced visual acuity, leading to difficulty reading or recognizing faces Decreased color vision, especially in central vision Blind spots or areas of abnormal vision in the central visual field Possible onset of pain or discomfort in the eyes, though less common

Diagnosis Path: Diagnosis of hereditary optic atrophy involves a combination of clinical assessment and specialized testing, including: - Detailed medical and family history to identify inheritance patterns - Visual acuity tests to evaluate the degree of vision loss - Ophthalmologic examination, including funduscopy, to observe optic nerve pallor - Visual field tests to assess the extent of vision impairment - Imaging studies like Optical Coherence Tomography (OCT) to examine the optic nerve structure - Genetic testing to identify mutations linked to the condition - Electroretinography (ERG) may be used to assess retinal function, although primarily the focus is on the optic nerve

Treatment Protocols: Currently, there is no cure for hereditary optic atrophy. Management strategies focus on supporting visual function and quality of life, and include: - Regular eye examinations to monitor vision changes - Visual aids, such as magnifiers or electronic devices, to assist with daily activities - Genetic counseling to understand inheritance risks and implications for family planning - Exploration of experimental therapies or clinical trials that aim to address mitochondrial dysfunction - Supportive services, including vision rehabilitation and psychological support, to cope with vision loss It is important for individuals affected by this condition to work closely with ophthalmologists and genetic specialists to tailor management plans suitable for their needs.